SS&C Prices IPO, Amag Gets $60M from Takeda, Selecta Nabs $15M, & More Boston-Area Deals News
Erin Kutz4/7/10Leave a CommentFollow @erkutz
Looks like the recent Boston sunshine helped plump up deal flow for the region’s software, Internet, and life sciences companies.
—Financial services software company SS&C Technologies Holdings, of Windsor, CT, set its IPO price at $15 a share, for a total of 10.725 million new shares. The price was at the high end of SS&C’s earlier proposed range. The initial public offering was worth nearly $161 million and put SS&C stock trading on the NASDAQ under the ticker symbol SSNC.
—Hangout Industries, a software platform provider for social games targeted toward teens, raised $2 million from existing investors, including Highland Capital Partners and Polaris Venture Partners. The Boston-based company’s CEO told Mass High Tech that another $3 million could be on the way, bringing Hangout’s funding total to $15 million.
—Lexington, MA-based Amag Pharmaceuticals (NASDAQ: AMAG) grabbed $60 million in upfront cash from a deal that gives Japan-based Takeda Pharmaceutical exclusive license rights to all therapeutic uses of ferumoxytol, Amag’s treatment for iron deficiency anemia, in Europe, former Soviet states, Asia Pacific countries (excluding China, Japan, and Taiwan), Canada, and Turkey.
—Cambridge, MA-based Cequent Pharmaceuticals and Bothell, WA’s MDRNA (NASDAQ: MRNA) announced they would merge in a $46 million, all-stock deal. The merger, expected to close in July, will … Next Page »
Erin Kutz is an Associate Editor for Xconomy. You can reach her by e-mail at ekutz@xconomy.com or by phone at (617) 252-0700, or follow her on Twitter at @erkutz.
